Sopharma AD Statistics

Total Valuation

Sopharma AD has a market cap or net worth of PLN 2.42 billion. The enterprise value is 3.57 billion.

Market Cap	2.42B
Enterprise Value	3.57B

Important Dates

The last earnings date was Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	Nov 7, 2024

Share Statistics

Current Share Class	166.36M
Shares Outstanding	n/a
Shares Change (YoY)	+24.34%
Shares Change (QoQ)	+4.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	38.38M

Valuation Ratios

The trailing PE ratio is 12.79.

PE Ratio	12.79
Forward PE	n/a
PS Ratio	0.50
PB Ratio	1.28
P/TBV Ratio	1.90
P/FCF Ratio	6.71
P/OCF Ratio	5.57
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.46, with an EV/FCF ratio of 9.91.

EV / Earnings	18.89
EV / Sales	0.72
EV / EBITDA	9.46
EV / EBIT	13.79
EV / FCF	9.91

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.62.

Current Ratio	1.24
Quick Ratio	0.63
Debt / Equity	0.62
Debt / EBITDA	3.93
Debt / FCF	3.26
Interest Coverage	5.89

Financial Efficiency

Return on equity (ROE) is 11.17% and return on invested capital (ROIC) is 4.07%.

Return on Equity (ROE)	11.17%
Return on Assets (ROA)	3.01%
Return on Invested Capital (ROIC)	4.07%
Return on Capital Employed (ROCE)	7.45%
Revenue Per Employee	796,179
Profits Per Employee	31,027
Employee Count	5,599
Asset Turnover	1.27
Inventory Turnover	4.30

Taxes

In the past 12 months, Sopharma AD has paid 25.52 million in taxes.

Income Tax	25.52M
Effective Tax Rate	11.16%

Stock Price Statistics

The stock price has increased by +3.07% in the last 52 weeks. The beta is -0.23, so Sopharma AD's price volatility has been lower than the market average.

Beta (5Y)	-0.23
52-Week Price Change	+3.07%
50-Day Moving Average	13.32
200-Day Moving Average	13.04
Relative Strength Index (RSI)	45.18
Average Volume (20 Days)	641

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sopharma AD had revenue of PLN 4.86 billion and earned 189.23 million in profits. Earnings per share was 1.08.

Revenue	4.86B
Gross Profit	1.07B
Operating Income	183.36M
Pretax Income	228.62M
Net Income	189.23M
EBITDA	264.09M
EBIT	183.36M
Earnings Per Share (EPS)	1.08

Full Income Statement

Balance Sheet

The company has 111.48 million in cash and 1.18 billion in debt, giving a net cash position of -1.06 billion.

Cash & Cash Equivalents	111.48M
Total Debt	1.18B
Net Cash	-1.06B
Net Cash Per Share	n/a
Equity (Book Value)	1.90B
Book Value Per Share	11.04
Working Capital	402.42M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 434.66 million and capital expenditures -74.02 million, giving a free cash flow of 360.63 million.

Operating Cash Flow	434.66M
Capital Expenditures	-74.02M
Free Cash Flow	360.63M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 21.96%, with operating and profit margins of 3.78% and 3.90%.

Gross Margin	21.96%
Operating Margin	3.78%
Pretax Margin	4.71%
Profit Margin	3.90%
EBITDA Margin	5.44%
EBIT Margin	3.78%
FCF Margin	7.43%

Dividends & Yields

This stock pays an annual dividend of 0.36, which amounts to a dividend yield of 2.70%.

Dividend Per Share	0.36
Dividend Yield	2.70%
Dividend Growth (YoY)	-89.19%
Years of Dividend Growth	n/a
Payout Ratio	190.42%
Buyback Yield	-24.34%
Shareholder Yield	-21.65%
Earnings Yield	7.82%
FCF Yield	14.90%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sopharma AD has an Altman Z-Score of 2.51 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.51
Piotroski F-Score	4